The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Forecasted Market Size Of The Cannabis Pharmaceuticals Market Compare Between 2026 And 2030?
The cannabis testing market has experienced rapid expansion in recent years. This market is set to increase from $3.56 billion in 2025 to $4.26 billion in 2026, achieving a compound annual growth rate (CAGR) of 19.8%. The growth observed in the past can be attributed to the proliferation of legalized cannabis markets, escalating regulatory safety mandates, the rise in commercial cannabis production, the embrace of laboratory-based quality testing, and the heightened necessity for consumer safety assurance.
The cannabis testing market is projected to experience substantial expansion over the coming years. Its size is anticipated to reach $8.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 19.6%. This projected growth during the forecast period stems from factors such as heightened investments in quick testing technologies, a surge in demand for instant potency analysis, the broadening of standardized testing rules, increased uptake of portable testing equipment, and the greater incorporation of digital laboratory management systems. Key developments expected during this period involve a rising need for extensive cannabis testing solutions, the growing use of sophisticated chromatography methods, an intensifying focus on tests for regulatory adherence, the wider deployment of mobile testing instruments, and improvements in data precision and tracking.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20723&type=smp
Which Major Factors Are Contributing To The Development Of The Cannabis Pharmaceuticals Market?
A rise in neurological conditions is anticipated to propel the expansion of the cannabis testing market moving forward. These conditions are defined as ailments impacting the nervous system, which includes the brain, spinal cord, and peripheral nerves, often leading to various cognitive, motor, and sensory impairments. Cannabis testing is employed in neurological conditions to analyze cannabinoids, exploring their potential therapeutic benefits and effects on symptoms like pain, spasticity, and seizures. For instance, in October 2023, the World Federation of Neurology, a UK-based association of national neurological societies, reported that over 40% of the global population was currently affected by some neurological condition, a burden projected to nearly double by 2050. Consequently, the increasing prevalence of neurological conditions is a significant driver for the cannabis testing market.
What Are The Major Segment Categories Within The Cannabis Pharmaceuticals Market?
The cannabis pharmaceuticals market covered in this report is segmented –
1) By Product Type: Cannabinoid-Based Pharmaceuticals, Synthetic Cannabinoids
2) By Therapeutic Application: Cancer, Neurological Disorders, Pain Management
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Government-Authorized Medical Cannabis Dispensaries
Subsegments:
1) By Cannabinoid-Based Pharmaceuticals: THC-Based Pharmaceuticals, CBD-Based Pharmaceuticals, Combination of THC and CBD Pharmaceuticals, Other Cannabinoid-Based Formulations
2) By Synthetic Cannabinoids: Synthetic THC Analogues, Synthetic CBD Analogues, Synthetic Cannabinoid Receptor Agonists
What Trends Are Driving Changes In The Cannabis Pharmaceuticals Market?
Major companies in the cannabis testing market are focused on developing innovative tests, such as roadside cannabis tests, to address the demand for accurate impairment assessment and to gain a competitive advantage. A roadside cannabis test serves as a diagnostic tool, employing neurodiagnostic methods to evaluate recent cannabis consumption and associated impairment. For instance, in April 2023, Oculogica, a US-based medical device manufacturing company, launched OcuPro, a roadside cannabis test that utilizes neurodiagnostic technology to assess recent cannabis use and its accompanying impairment. This device, piloted in several Missouri police departments, records and analyzes eye-pupil characteristics to differentiate between recent use within 60-90 minutes and use from several hours prior. Unlike traditional tests that rely on THC analysis from body samples, OcuPro directly meets the need for a scientifically validated test for impairment from recent cannabis use, which is crucial for enforcing laws against driving under the influence.
Who Are The Major Companies Operating In The Cannabis Pharmaceuticals Market?
Major companies operating in the cannabis pharmaceuticals market are Tilray Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Aphria Inc., Cronos Group, GW Pharmaceuticals plc, Jazz Pharmaceuticals plc, Organigram Holdings Inc., Aleafia Health Inc., Avicanna Inc., Enveric Biosciences Inc., Auxly Cannabis Group Inc., Emerald Health Therapeutics Inc., Medical Marijuana Inc., Valens Company Inc., Curaleaf Holdings Inc., Trulieve Cannabis Corp., Green Thumb Industries Inc., Cresco Labs Inc., Columbia Care Inc., Acreage Holdings Inc.
Access The Complete Cannabis Pharmaceuticals Market Report:
https://www.thebusinessresearchcompany.com/report/cannabis-pharmaceuticals-global-market-report
Which Region Is The Primary Market For The Cannabis Pharmaceuticals Market?
North America was the largest region in the cannabis pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cannabis pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Cannabis Pharmaceuticals Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=20723&type=smp
Browse Through More Reports Similar to the Global Cannabis Pharmaceuticals Market 2026, By The Business Research Company
Cannabis Capsule Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/cannabis-capsule-global-market-report
Recreational Cannabis Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/recreational-cannabis-global-market-report
Plant Extracts Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/plant-extracts-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model